Segment Information (Tables)

12 Months Ended

Sep. 27, 2026

Segment Reporting [Abstract]

Revenues, EBT, and Assets for reportable segments

The table below presents revenues, EBT and significant expense categories regularly provided to the CODM for reportable segments (in millions):

	2026		2025		2024
QCT:
Revenues	$	37,208	$	38,367	$	33,196
Cost of revenues	19,460		19,302		16,648
Operating expenses (R&D and SG&A)	7,647		7,395		7,021
EBT	$	10,101	$	11,670	$	9,527
QTL:
Revenues	$	5,556	$	5,582	$	5,572
Costs and expenses (1)	1,534		1,539		1,545
EBT	$	4,022	$	4,043	$	4,027
QSI:
Revenues	$	—	$	—	$	18
Cost of revenues	—		—		7
Operating expenses	11		13		12
Investment and other income, net	805		193		105
EBT	$	794	$	180	$	104

(1) Substantially all of QTL’s costs and expenses are comprised of operating expenses.

Reconciling items for reportable segments - revenues

Consolidated revenues and EBT include the following reconciling items (in millions):

	2026		2025		2024
Revenues:
Reportable segments	$	42,764	$	43,949	$	38,786
Nonreportable segments	476		192		176
Unallocated revenues	(120)		143		—
	$	43,120	$	44,284	$	38,962
EBT:
Reportable segments	$	14,917	$	15,893	$	13,658
Nonreportable segments	(607)		(39)		(14)
Unallocated revenues	(120)		143		—
Unallocated cost of revenues	(400)		(270)		(229)
Unallocated research and development expenses	(2,829)		(2,357)		(2,277)
Unallocated selling, general and administrative expenses	(1,166)		(783)		(781)
Unallocated other expense	(332)		(39)		(179)
Unallocated interest expense	(689)		(664)		(697)
Unallocated investment and other income, net	640		779		855
	$	9,414	$	12,663	$	10,336

Reconciling items for reportable segments - EBT

Consolidated revenues and EBT include the following reconciling items (in millions):

	2026		2025		2024
Revenues:
Reportable segments	$	42,764	$	43,949	$	38,786
Nonreportable segments	476		192		176
Unallocated revenues	(120)		143		—
	$	43,120	$	44,284	$	38,962
EBT:
Reportable segments	$	14,917	$	15,893	$	13,658
Nonreportable segments	(607)		(39)		(14)
Unallocated revenues	(120)		143		—
Unallocated cost of revenues	(400)		(270)		(229)
Unallocated research and development expenses	(2,829)		(2,357)		(2,277)
Unallocated selling, general and administrative expenses	(1,166)		(783)		(781)
Unallocated other expense	(332)		(39)		(179)
Unallocated interest expense	(689)		(664)		(697)
Unallocated investment and other income, net	640		779		855
	$	9,414	$	12,663	$	10,336

Revenue from external customers attributed to foreign countries by geographic area

We report revenues by country based on our customer’s/licensee’s headquarters. As a result, the revenues by country presented herein are not necessarily indicative of the country in which the device containing our products and/or intellectual property are ultimately sold to consumers. Revenues by country were as follows (in millions, except percentages):

	2026				2025				2024
China (including Hong Kong)	$	18,079	42	%	$	20,340	46	%	$	17,826	46	%
United States	10,792		25		10,515		24		9,686		25
South Korea	9,467		22		9,542		21		7,995		20
Other foreign	4,782		11		3,887		9		3,455		9
	$	43,120	100	%	$	44,284	100	%	$	38,962	100	%